Skip to main content

Table 2 Characteristics of the patients exposed to corticosteroids included in the study

From: Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19

Patient Age range
(years)
Indication Drug Daily dose, mg Duration Comorbidities Clinical finding Biological
findings
Chest CT-scan severity score Outcome
#1 31–40 Multiple myeloma Dexamethasone 40 3 months Overweight, cancer, multiple myeloma Moderate No
#2 61–70 Crohn disease Prednisolone NA Long-term Overweight, chronic lung disease, Crohn disease Need of oxygen Lymphopenia,
C-reactive protein ≥50 mg/L
Severe ICU, mechanical ventilation, death
#3 81–90 Horton disease Prednisolone 2.5 Long-term Hypertension, coronaropathy, diabetes SaO2 ≤ 92% Lymphopenia, thrombocytopenia,
C-reactive protein ≥50 mg/L
Severe Death
#4 71–80 Glioblastoma Prednisone 20 1 year Malignancy Lymphopenia Moderate Death
#5 51–60 Bronchitis Prednisolone 60 4 days Overweight, hypertension Moderate No
#6 81–90 Sarcoidosis Prednisone 20 4 days Overweight, hypertension, sarcoidosis, sleep apnea SaO2 ≤ 92% C-reactive protein ≥50 mg/L Moderate No
#7 61–70 Renal transplant Prednisone 5 7 years Overweight, hypertension, sleep apnea, diabetes, chronic kidney disease, renal transplant Lymphopenia, thrombocytopenia Moderate ICU
#8 41–50 Cardiac transplant Prednisone 5 11 years Cardiac surgery, cardiac transplant Absence No
#9 81–90 Giant cell arteritis Prednisone 3 4 years Obesity, hypertension, heart failure, coronaropathy, sleep apnea, chronic kidney disease, diabetes, giant cell arteritis SaO2 ≤ 92% Lymphopenia,
C-reactive protein ≥50 mg/L
Moderate ICU, Death
#10 91–100 Lymphoma Prednisolone 60 8 months Chronic lung disease, diabetes, lymphoma Lymphopenia Moderate No
#11 21–30 Crohn disease Prednisolone 25 5 months Immunosuppression C-reactive protein ≥50 mg/L Moderate No
#12 71–80 Oesophageal adenocarcinoma Betametasone 0.4 (30 drops) 3 months Overweight, coronaropathy, sleep apnea, malignancy Lymphopenia, thrombocytopenia, Moderate ICU
#13 71–80 Renal transplant Prednisone 5 5 months Hypertension, chronic kidney disease, chronic liver disease, diabetes, renal transplant Lymphopenia,
C-reactive protein ≥50 mg/L
Moderate ICU, mechanical ventilation
#14 61–70 Renal transplant Prednisone 5 2 years Hypertension, cerebrovascular disease, sleep apnea, chronic kidney disease, renal transplant Lymphopenia, thrombocytopenia, Moderate ICU, mechanical ventilation
#15 71–80 Rheumatoid arthritis NA NA 6 weeks Hypertension, rheumatoid arthritis Lymphopenia Moderate No
#16 61–70 Sarcoidosis Prednisone 6.5 1 year Obesity, hypertension, COPD, sarcoidosis Lymphopenia Mild ICU, death
#17 81–90 Dermatomyositis Prednisone 70 1 month Hypertension, lung fibrosis, malignancy dermatomyositis Need of oxygen Lymphopenia, thrombocytopenia,
C-reactive protein ≥50 mg/L
Severe Death
  1. Abbreviation: COPD chronic obstructive pulmonary disease, NA Not available